• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • A. Eggermont, V. Chiarion-Sileni, +19 authors A. Testori
  • Medicine
  • The Lancet. Oncology
  • 2015 (First Publication: 1 May 2015)
  • BACKGROUND Ipilimumab is an approved treatment for patients with advanced melanoma. We aimed to assess ipilimumab as adjuvant therapy for patients with completely resected stage III melanoma at highExpand
  • A. M. M. Eggermont, Stefan Suciu, Mario Santinami, Alessandro Testori, for the Eortc Melanoma Group
  • Medicine
  • The Lancet
  • 2008 (First Publication: 12 July 2008)
  • BACKGROUND Any benefit of adjuvant interferon alfa-2b for melanoma could depend on dose and duration of treatment. Our aim was to determine whether pegylated interferon alfa-2b can facilitateExpand
  • F. Belli, A. Testori, +26 authors G. Parmiani
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2002 (First Publication: 15 October 2002)
  • PURPOSE To determine the immunogenicity and antitumor activity of a vaccine consisting of autologous, tumor-derived heat shock protein gp96-peptide complexes (HSPPC-96, Oncophage; Antigenics, Inc,Expand
  • P. Chapman, A. Hauschild, +17 authors G. McArthur
  • Medicine
  • 2012 (First Publication: 20 May 2012)
  • Background: We previously reported results of the planned OS interim analysis for BRIM-3 (50% of the planned 196 deaths required for final analysis) at which time the independent Data SafetyExpand